Global Acilizumab Market Growth 2026-2032
The global Acilizumab market size is predicted to grow from US$ 333 million in 2025 to US$ 1040 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Acilizumab is a monoclonal antibody drug that targets the interleukin-6 (IL-6) pathway. It exerts anti-inflammatory and immunomodulatory effects by binding to the IL-6 receptor and inhibiting inflammatory signal transduction. The drug is widely used in the treatment of autoimmune diseases such as rheumatoid arthritis, and it also has significant clinical value in inflammatory conditions like cytokine release syndrome. As a biologic agent, Acilizumab demonstrates high specificity and efficacy, showing notable benefits in improving patient symptoms and slowing disease progression, and has become an important therapeutic option in the field of IL-6 inhibitors.In 2025, global production of axatilimab reached approximately 15,000 vials.
Acilizumab, as a monoclonal antibody targeting the interleukin-6 (IL-6) pathway, holds an important position in the treatment market for autoimmune and inflammatory diseases. With the continuous increase in the number of patients with chronic conditions such as rheumatoid arthritis, along with the growing demand for precise immunomodulatory therapies, the IL-6 inhibitor market is maintaining steady growth. From a competitive landscape perspective, the field consists of originator drugs and multiple biosimilars, leading to intensifying competition, which in turn improves product accessibility and drives price reductions. On a global scale, Acilizumab has strong penetration in hospital channels and specialty care settings, with particularly significant growth potential in emerging markets. Looking ahead, with further expansion of indications (such as inflammatory syndromes) and broader medical insurance coverage, the market size of Acilizumab is expected to continue growing, maintaining its important role in the IL-6 targeted therapy landscape.
LP Information, Inc. (LPI) ' newest research report, the ?Acilizumab Industry Forecast? looks at past sales and reviews total world Acilizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Acilizumab sales for 2026 through 2032. With Acilizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acilizumab industry.
This Insight Report provides a comprehensive analysis of the global Acilizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acilizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acilizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acilizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acilizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Acilizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Acilizumab market?
What factors are driving Acilizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acilizumab market opportunities vary by end market size?
How does Acilizumab break out by Type, by Application?
Acilizumab is a monoclonal antibody drug that targets the interleukin-6 (IL-6) pathway. It exerts anti-inflammatory and immunomodulatory effects by binding to the IL-6 receptor and inhibiting inflammatory signal transduction. The drug is widely used in the treatment of autoimmune diseases such as rheumatoid arthritis, and it also has significant clinical value in inflammatory conditions like cytokine release syndrome. As a biologic agent, Acilizumab demonstrates high specificity and efficacy, showing notable benefits in improving patient symptoms and slowing disease progression, and has become an important therapeutic option in the field of IL-6 inhibitors.In 2025, global production of axatilimab reached approximately 15,000 vials.
Acilizumab, as a monoclonal antibody targeting the interleukin-6 (IL-6) pathway, holds an important position in the treatment market for autoimmune and inflammatory diseases. With the continuous increase in the number of patients with chronic conditions such as rheumatoid arthritis, along with the growing demand for precise immunomodulatory therapies, the IL-6 inhibitor market is maintaining steady growth. From a competitive landscape perspective, the field consists of originator drugs and multiple biosimilars, leading to intensifying competition, which in turn improves product accessibility and drives price reductions. On a global scale, Acilizumab has strong penetration in hospital channels and specialty care settings, with particularly significant growth potential in emerging markets. Looking ahead, with further expansion of indications (such as inflammatory syndromes) and broader medical insurance coverage, the market size of Acilizumab is expected to continue growing, maintaining its important role in the IL-6 targeted therapy landscape.
LP Information, Inc. (LPI) ' newest research report, the ?Acilizumab Industry Forecast? looks at past sales and reviews total world Acilizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Acilizumab sales for 2026 through 2032. With Acilizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acilizumab industry.
This Insight Report provides a comprehensive analysis of the global Acilizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acilizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acilizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acilizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acilizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Acilizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intravenous, IV
- Subcutaneous, SC
- 80 mg / 4 mL
- 200 mg / 10 mL
- Innovator
- Generic
- Hospital
- Retail
- Online
- Rheumatoid Arthritis, RA
- Systemic Juvenile Idiopathic Arthritis
- Cytokine Release Syndrome (CRS)
- Giant Cell Arteritis, GCA
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chugai Pharmaceutical
- F. Hoffmann-La Roche
- Genentech
- Celltrion
- Fresenius Kabi
- Biogen
What is the 10-year outlook for the global Acilizumab market?
What factors are driving Acilizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acilizumab market opportunities vary by end market size?
How does Acilizumab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acilizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Acilizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Acilizumab by Country/Region, 2021, 2025 & 2032
2.2 Acilizumab Segment by Type
2.2.1 Intravenous, IV
2.2.2 Subcutaneous, SC
2.2.3 Acilizumab Sales by Type
2.2.3.1 Global Acilizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Acilizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Acilizumab Sale Price by Type (2021-2026)
2.3 Acilizumab Segment by Specifications
2.3.1 80 mg / 4 mL
2.3.2 200 mg / 10 mL
2.3.3 Acilizumab Sales by Specifications
2.3.3.1 Global Acilizumab Sales Market Share by Specifications (2021-2026)
2.3.3.2 Global Acilizumab Revenue and Market Share by Specifications (2021-2026)
2.3.3.3 Global Acilizumab Sale Price by Specifications (2021-2026)
2.4 Acilizumab Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Acilizumab Sales by Production Technology
2.4.3.1 Global Acilizumab Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Acilizumab Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Acilizumab Sale Price by Production Technology (2021-2026)
2.5 Acilizumab Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Acilizumab Sales by Sales Channels
2.5.4.1 Global Acilizumab Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Acilizumab Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Acilizumab Sale Price by Sales Channels (2021-2026)
2.6 Acilizumab Segment by Application
2.6.1 Rheumatoid Arthritis, RA
2.6.2 Systemic Juvenile Idiopathic Arthritis
2.6.3 Cytokine Release Syndrome (CRS)
2.6.4 Giant Cell Arteritis, GCA
2.6.5 Others
2.6.6 Acilizumab Sales by Application
2.6.6.1 Global Acilizumab Sale Market Share by Application (2021-2026)
2.6.6.2 Global Acilizumab Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Acilizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Acilizumab Breakdown Data by Company
3.1.1 Global Acilizumab Annual Sales by Company (2021-2026)
3.1.2 Global Acilizumab Sales Market Share by Company (2021-2026)
3.2 Global Acilizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Acilizumab Revenue by Company (2021-2026)
3.2.2 Global Acilizumab Revenue Market Share by Company (2021-2026)
3.3 Global Acilizumab Sale Price by Company
3.4 Key Manufacturers Acilizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acilizumab Product Location Distribution
3.4.2 Players Acilizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACILIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Acilizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Acilizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Acilizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Acilizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Acilizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Acilizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acilizumab Sales Growth
4.4 APAC Acilizumab Sales Growth
4.5 Europe Acilizumab Sales Growth
4.6 Middle East & Africa Acilizumab Sales Growth
5 AMERICAS
5.1 Americas Acilizumab Sales by Country
5.1.1 Americas Acilizumab Sales by Country (2021-2026)
5.1.2 Americas Acilizumab Revenue by Country (2021-2026)
5.2 Americas Acilizumab Sales by Type (2021-2026)
5.3 Americas Acilizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acilizumab Sales by Region
6.1.1 APAC Acilizumab Sales by Region (2021-2026)
6.1.2 APAC Acilizumab Revenue by Region (2021-2026)
6.2 APAC Acilizumab Sales by Type (2021-2026)
6.3 APAC Acilizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acilizumab by Country
7.1.1 Europe Acilizumab Sales by Country (2021-2026)
7.1.2 Europe Acilizumab Revenue by Country (2021-2026)
7.2 Europe Acilizumab Sales by Type (2021-2026)
7.3 Europe Acilizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acilizumab by Country
8.1.1 Middle East & Africa Acilizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Acilizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Acilizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Acilizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acilizumab
10.3 Manufacturing Process Analysis of Acilizumab
10.4 Industry Chain Structure of Acilizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acilizumab Distributors
11.3 Acilizumab Customer
12 WORLD FORECAST REVIEW FOR ACILIZUMAB BY GEOGRAPHIC REGION
12.1 Global Acilizumab Market Size Forecast by Region
12.1.1 Global Acilizumab Forecast by Region (2027-2032)
12.1.2 Global Acilizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Acilizumab Forecast by Type (2027-2032)
12.7 Global Acilizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chugai Pharmaceutical
13.1.1 Chugai Pharmaceutical Company Information
13.1.2 Chugai Pharmaceutical Acilizumab Product Portfolios and Specifications
13.1.3 Chugai Pharmaceutical Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chugai Pharmaceutical Main Business Overview
13.1.5 Chugai Pharmaceutical Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Acilizumab Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Genentech
13.3.1 Genentech Company Information
13.3.2 Genentech Acilizumab Product Portfolios and Specifications
13.3.3 Genentech Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Genentech Main Business Overview
13.3.5 Genentech Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Acilizumab Product Portfolios and Specifications
13.4.3 Celltrion Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Information
13.5.2 Fresenius Kabi Acilizumab Product Portfolios and Specifications
13.5.3 Fresenius Kabi Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fresenius Kabi Main Business Overview
13.5.5 Fresenius Kabi Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Acilizumab Product Portfolios and Specifications
13.6.3 Biogen Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acilizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Acilizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Acilizumab by Country/Region, 2021, 2025 & 2032
2.2 Acilizumab Segment by Type
2.2.1 Intravenous, IV
2.2.2 Subcutaneous, SC
2.2.3 Acilizumab Sales by Type
2.2.3.1 Global Acilizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Acilizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Acilizumab Sale Price by Type (2021-2026)
2.3 Acilizumab Segment by Specifications
2.3.1 80 mg / 4 mL
2.3.2 200 mg / 10 mL
2.3.3 Acilizumab Sales by Specifications
2.3.3.1 Global Acilizumab Sales Market Share by Specifications (2021-2026)
2.3.3.2 Global Acilizumab Revenue and Market Share by Specifications (2021-2026)
2.3.3.3 Global Acilizumab Sale Price by Specifications (2021-2026)
2.4 Acilizumab Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Acilizumab Sales by Production Technology
2.4.3.1 Global Acilizumab Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Acilizumab Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Acilizumab Sale Price by Production Technology (2021-2026)
2.5 Acilizumab Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Acilizumab Sales by Sales Channels
2.5.4.1 Global Acilizumab Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Acilizumab Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Acilizumab Sale Price by Sales Channels (2021-2026)
2.6 Acilizumab Segment by Application
2.6.1 Rheumatoid Arthritis, RA
2.6.2 Systemic Juvenile Idiopathic Arthritis
2.6.3 Cytokine Release Syndrome (CRS)
2.6.4 Giant Cell Arteritis, GCA
2.6.5 Others
2.6.6 Acilizumab Sales by Application
2.6.6.1 Global Acilizumab Sale Market Share by Application (2021-2026)
2.6.6.2 Global Acilizumab Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Acilizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Acilizumab Breakdown Data by Company
3.1.1 Global Acilizumab Annual Sales by Company (2021-2026)
3.1.2 Global Acilizumab Sales Market Share by Company (2021-2026)
3.2 Global Acilizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Acilizumab Revenue by Company (2021-2026)
3.2.2 Global Acilizumab Revenue Market Share by Company (2021-2026)
3.3 Global Acilizumab Sale Price by Company
3.4 Key Manufacturers Acilizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acilizumab Product Location Distribution
3.4.2 Players Acilizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACILIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Acilizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Acilizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Acilizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Acilizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Acilizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Acilizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acilizumab Sales Growth
4.4 APAC Acilizumab Sales Growth
4.5 Europe Acilizumab Sales Growth
4.6 Middle East & Africa Acilizumab Sales Growth
5 AMERICAS
5.1 Americas Acilizumab Sales by Country
5.1.1 Americas Acilizumab Sales by Country (2021-2026)
5.1.2 Americas Acilizumab Revenue by Country (2021-2026)
5.2 Americas Acilizumab Sales by Type (2021-2026)
5.3 Americas Acilizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acilizumab Sales by Region
6.1.1 APAC Acilizumab Sales by Region (2021-2026)
6.1.2 APAC Acilizumab Revenue by Region (2021-2026)
6.2 APAC Acilizumab Sales by Type (2021-2026)
6.3 APAC Acilizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acilizumab by Country
7.1.1 Europe Acilizumab Sales by Country (2021-2026)
7.1.2 Europe Acilizumab Revenue by Country (2021-2026)
7.2 Europe Acilizumab Sales by Type (2021-2026)
7.3 Europe Acilizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acilizumab by Country
8.1.1 Middle East & Africa Acilizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Acilizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Acilizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Acilizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acilizumab
10.3 Manufacturing Process Analysis of Acilizumab
10.4 Industry Chain Structure of Acilizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acilizumab Distributors
11.3 Acilizumab Customer
12 WORLD FORECAST REVIEW FOR ACILIZUMAB BY GEOGRAPHIC REGION
12.1 Global Acilizumab Market Size Forecast by Region
12.1.1 Global Acilizumab Forecast by Region (2027-2032)
12.1.2 Global Acilizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Acilizumab Forecast by Type (2027-2032)
12.7 Global Acilizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chugai Pharmaceutical
13.1.1 Chugai Pharmaceutical Company Information
13.1.2 Chugai Pharmaceutical Acilizumab Product Portfolios and Specifications
13.1.3 Chugai Pharmaceutical Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chugai Pharmaceutical Main Business Overview
13.1.5 Chugai Pharmaceutical Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Acilizumab Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Genentech
13.3.1 Genentech Company Information
13.3.2 Genentech Acilizumab Product Portfolios and Specifications
13.3.3 Genentech Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Genentech Main Business Overview
13.3.5 Genentech Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Acilizumab Product Portfolios and Specifications
13.4.3 Celltrion Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Information
13.5.2 Fresenius Kabi Acilizumab Product Portfolios and Specifications
13.5.3 Fresenius Kabi Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Fresenius Kabi Main Business Overview
13.5.5 Fresenius Kabi Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Acilizumab Product Portfolios and Specifications
13.6.3 Biogen Acilizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acilizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Acilizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous, IV
Table 4. Major Players of Subcutaneous, SC
Table 5. Global Acilizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Acilizumab Sales Market Share by Type (2021-2026)
Table 7. Global Acilizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Acilizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Acilizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 80 mg / 4 mL
Table 11. Major Players of 200 mg / 10 mL
Table 12. Global Acilizumab Sales by Specifications (2021-2026) & (Units)
Table 13. Global Acilizumab Sales Market Share by Specifications (2021-2026)
Table 14. Global Acilizumab Revenue by Specifications (2021-2026) & ($ million)
Table 15. Global Acilizumab Revenue Market Share by Specifications (2021-2026)
Table 16. Global Acilizumab Sale Price by Specifications (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Acilizumab Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Acilizumab Sales Market Share by Production Technology (2021-2026)
Table 21. Global Acilizumab Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Acilizumab Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Acilizumab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Acilizumab Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Acilizumab Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Acilizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Acilizumab Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Acilizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Acilizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Acilizumab Sale Market Share by Application (2021-2026)
Table 34. Global Acilizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Acilizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Acilizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Acilizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Acilizumab Sales Market Share by Company (2021-2026)
Table 39. Global Acilizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Acilizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Acilizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Acilizumab Producing Area Distribution and Sales Area
Table 43. Players Acilizumab Products Offered
Table 44. Acilizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Acilizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Acilizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Acilizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Acilizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Acilizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Acilizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Acilizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Acilizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Acilizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Acilizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Acilizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Acilizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Acilizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Acilizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Acilizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Acilizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Acilizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Acilizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Acilizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Acilizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Acilizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Acilizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Acilizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Acilizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Acilizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Acilizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Acilizumab
Table 74. Key Market Challenges & Risks of Acilizumab
Table 75. Key Industry Trends of Acilizumab
Table 76. Acilizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Acilizumab Distributors List
Table 79. Acilizumab Customer List
Table 80. Global Acilizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Acilizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Acilizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Acilizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Acilizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Acilizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Acilizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Acilizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Acilizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Acilizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Acilizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Chugai Pharmaceutical Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Chugai Pharmaceutical Acilizumab Product Portfolios and Specifications
Table 96. Chugai Pharmaceutical Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Chugai Pharmaceutical Main Business
Table 98. Chugai Pharmaceutical Latest Developments
Table 99. F. Hoffmann-La Roche Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Acilizumab Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. F. Hoffmann-La Roche Main Business
Table 103. F. Hoffmann-La Roche Latest Developments
Table 104. Genentech Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 105. Genentech Acilizumab Product Portfolios and Specifications
Table 106. Genentech Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Genentech Main Business
Table 108. Genentech Latest Developments
Table 109. Celltrion Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 110. Celltrion Acilizumab Product Portfolios and Specifications
Table 111. Celltrion Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Celltrion Main Business
Table 113. Celltrion Latest Developments
Table 114. Fresenius Kabi Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 115. Fresenius Kabi Acilizumab Product Portfolios and Specifications
Table 116. Fresenius Kabi Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Fresenius Kabi Main Business
Table 118. Fresenius Kabi Latest Developments
Table 119. Biogen Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 120. Biogen Acilizumab Product Portfolios and Specifications
Table 121. Biogen Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Biogen Main Business
Table 123. Biogen Latest Developments
Table 1. Acilizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Acilizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous, IV
Table 4. Major Players of Subcutaneous, SC
Table 5. Global Acilizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Acilizumab Sales Market Share by Type (2021-2026)
Table 7. Global Acilizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Acilizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Acilizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 80 mg / 4 mL
Table 11. Major Players of 200 mg / 10 mL
Table 12. Global Acilizumab Sales by Specifications (2021-2026) & (Units)
Table 13. Global Acilizumab Sales Market Share by Specifications (2021-2026)
Table 14. Global Acilizumab Revenue by Specifications (2021-2026) & ($ million)
Table 15. Global Acilizumab Revenue Market Share by Specifications (2021-2026)
Table 16. Global Acilizumab Sale Price by Specifications (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Acilizumab Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Acilizumab Sales Market Share by Production Technology (2021-2026)
Table 21. Global Acilizumab Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Acilizumab Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Acilizumab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Acilizumab Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Acilizumab Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Acilizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Acilizumab Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Acilizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Acilizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Acilizumab Sale Market Share by Application (2021-2026)
Table 34. Global Acilizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Acilizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Acilizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Acilizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Acilizumab Sales Market Share by Company (2021-2026)
Table 39. Global Acilizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Acilizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Acilizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Acilizumab Producing Area Distribution and Sales Area
Table 43. Players Acilizumab Products Offered
Table 44. Acilizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Acilizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Acilizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Acilizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Acilizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Acilizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Acilizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Acilizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Acilizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Acilizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Acilizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Acilizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Acilizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Acilizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Acilizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Acilizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Acilizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Acilizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Acilizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Acilizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Acilizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Acilizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Acilizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Acilizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Acilizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Acilizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Acilizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Acilizumab
Table 74. Key Market Challenges & Risks of Acilizumab
Table 75. Key Industry Trends of Acilizumab
Table 76. Acilizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Acilizumab Distributors List
Table 79. Acilizumab Customer List
Table 80. Global Acilizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Acilizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Acilizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Acilizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Acilizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Acilizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Acilizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Acilizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Acilizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Acilizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Acilizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Acilizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Chugai Pharmaceutical Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Chugai Pharmaceutical Acilizumab Product Portfolios and Specifications
Table 96. Chugai Pharmaceutical Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Chugai Pharmaceutical Main Business
Table 98. Chugai Pharmaceutical Latest Developments
Table 99. F. Hoffmann-La Roche Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Acilizumab Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. F. Hoffmann-La Roche Main Business
Table 103. F. Hoffmann-La Roche Latest Developments
Table 104. Genentech Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 105. Genentech Acilizumab Product Portfolios and Specifications
Table 106. Genentech Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Genentech Main Business
Table 108. Genentech Latest Developments
Table 109. Celltrion Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 110. Celltrion Acilizumab Product Portfolios and Specifications
Table 111. Celltrion Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Celltrion Main Business
Table 113. Celltrion Latest Developments
Table 114. Fresenius Kabi Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 115. Fresenius Kabi Acilizumab Product Portfolios and Specifications
Table 116. Fresenius Kabi Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Fresenius Kabi Main Business
Table 118. Fresenius Kabi Latest Developments
Table 119. Biogen Basic Information, Acilizumab Manufacturing Base, Sales Area and Its Competitors
Table 120. Biogen Acilizumab Product Portfolios and Specifications
Table 121. Biogen Acilizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Biogen Main Business
Table 123. Biogen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Acilizumab
Figure 2. Acilizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acilizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Acilizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Acilizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Acilizumab Sales Market Share by Country/Region (2025)
Figure 10. Acilizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous, IV
Figure 12. Product Picture of Subcutaneous, SC
Figure 13. Global Acilizumab Sales Market Share by Type in 2026
Figure 14. Global Acilizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 80 mg / 4 mL
Figure 16. Product Picture of 200 mg / 10 mL
Figure 17. Global Acilizumab Sales Market Share by Specifications in 2026
Figure 18. Global Acilizumab Revenue Market Share by Specifications (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Acilizumab Sales Market Share by Production Technology in 2026
Figure 22. Global Acilizumab Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Acilizumab Sales Market Share by Sales Channels in 2026
Figure 27. Global Acilizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Acilizumab Consumed in Rheumatoid Arthritis, RA
Figure 29. Global Acilizumab Market: Rheumatoid Arthritis, RA (2021-2026) & (Units)
Figure 30. Acilizumab Consumed in Systemic Juvenile Idiopathic Arthritis
Figure 31. Global Acilizumab Market: Systemic Juvenile Idiopathic Arthritis (2021-2026) & (Units)
Figure 32. Acilizumab Consumed in Cytokine Release Syndrome (CRS)
Figure 33. Global Acilizumab Market: Cytokine Release Syndrome (CRS) (2021-2026) & (Units)
Figure 34. Acilizumab Consumed in Giant Cell Arteritis, GCA
Figure 35. Global Acilizumab Market: Giant Cell Arteritis, GCA (2021-2026) & (Units)
Figure 36. Acilizumab Consumed in Others
Figure 37. Global Acilizumab Market: Others (2021-2026) & (Units)
Figure 38. Global Acilizumab Sale Market Share by Application (2025)
Figure 39. Global Acilizumab Revenue Market Share by Application in 2025
Figure 40. Acilizumab Sales by Company in 2025 (Units)
Figure 41. Global Acilizumab Sales Market Share by Company in 2025
Figure 42. Acilizumab Revenue by Company in 2025 ($ millions)
Figure 43. Global Acilizumab Revenue Market Share by Company in 2025
Figure 44. Global Acilizumab Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Acilizumab Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Acilizumab Sales 2021-2026 (Units)
Figure 47. Americas Acilizumab Revenue 2021-2026 ($ millions)
Figure 48. APAC Acilizumab Sales 2021-2026 (Units)
Figure 49. APAC Acilizumab Revenue 2021-2026 ($ millions)
Figure 50. Europe Acilizumab Sales 2021-2026 (Units)
Figure 51. Europe Acilizumab Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Acilizumab Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Acilizumab Revenue 2021-2026 ($ millions)
Figure 54. Americas Acilizumab Sales Market Share by Country in 2025
Figure 55. Americas Acilizumab Revenue Market Share by Country (2021-2026)
Figure 56. Americas Acilizumab Sales Market Share by Type (2021-2026)
Figure 57. Americas Acilizumab Sales Market Share by Application (2021-2026)
Figure 58. United States Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Acilizumab Sales Market Share by Region in 2025
Figure 63. APAC Acilizumab Revenue Market Share by Region (2021-2026)
Figure 64. APAC Acilizumab Sales Market Share by Type (2021-2026)
Figure 65. APAC Acilizumab Sales Market Share by Application (2021-2026)
Figure 66. China Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. India Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Acilizumab Sales Market Share by Country in 2025
Figure 74. Europe Acilizumab Revenue Market Share by Country (2021-2026)
Figure 75. Europe Acilizumab Sales Market Share by Type (2021-2026)
Figure 76. Europe Acilizumab Sales Market Share by Application (2021-2026)
Figure 77. Germany Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. France Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Acilizumab Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Acilizumab Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Acilizumab Sales Market Share by Application (2021-2026)
Figure 85. Egypt Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Acilizumab in 2026
Figure 91. Manufacturing Process Analysis of Acilizumab
Figure 92. Industry Chain Structure of Acilizumab
Figure 93. Channels of Distribution
Figure 94. Global Acilizumab Sales Market Forecast by Region (2027-2032)
Figure 95. Global Acilizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Acilizumab Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Acilizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Acilizumab Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Acilizumab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Acilizumab
Figure 2. Acilizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acilizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Acilizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Acilizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Acilizumab Sales Market Share by Country/Region (2025)
Figure 10. Acilizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous, IV
Figure 12. Product Picture of Subcutaneous, SC
Figure 13. Global Acilizumab Sales Market Share by Type in 2026
Figure 14. Global Acilizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 80 mg / 4 mL
Figure 16. Product Picture of 200 mg / 10 mL
Figure 17. Global Acilizumab Sales Market Share by Specifications in 2026
Figure 18. Global Acilizumab Revenue Market Share by Specifications (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Acilizumab Sales Market Share by Production Technology in 2026
Figure 22. Global Acilizumab Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Acilizumab Sales Market Share by Sales Channels in 2026
Figure 27. Global Acilizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Acilizumab Consumed in Rheumatoid Arthritis, RA
Figure 29. Global Acilizumab Market: Rheumatoid Arthritis, RA (2021-2026) & (Units)
Figure 30. Acilizumab Consumed in Systemic Juvenile Idiopathic Arthritis
Figure 31. Global Acilizumab Market: Systemic Juvenile Idiopathic Arthritis (2021-2026) & (Units)
Figure 32. Acilizumab Consumed in Cytokine Release Syndrome (CRS)
Figure 33. Global Acilizumab Market: Cytokine Release Syndrome (CRS) (2021-2026) & (Units)
Figure 34. Acilizumab Consumed in Giant Cell Arteritis, GCA
Figure 35. Global Acilizumab Market: Giant Cell Arteritis, GCA (2021-2026) & (Units)
Figure 36. Acilizumab Consumed in Others
Figure 37. Global Acilizumab Market: Others (2021-2026) & (Units)
Figure 38. Global Acilizumab Sale Market Share by Application (2025)
Figure 39. Global Acilizumab Revenue Market Share by Application in 2025
Figure 40. Acilizumab Sales by Company in 2025 (Units)
Figure 41. Global Acilizumab Sales Market Share by Company in 2025
Figure 42. Acilizumab Revenue by Company in 2025 ($ millions)
Figure 43. Global Acilizumab Revenue Market Share by Company in 2025
Figure 44. Global Acilizumab Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Acilizumab Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Acilizumab Sales 2021-2026 (Units)
Figure 47. Americas Acilizumab Revenue 2021-2026 ($ millions)
Figure 48. APAC Acilizumab Sales 2021-2026 (Units)
Figure 49. APAC Acilizumab Revenue 2021-2026 ($ millions)
Figure 50. Europe Acilizumab Sales 2021-2026 (Units)
Figure 51. Europe Acilizumab Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Acilizumab Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Acilizumab Revenue 2021-2026 ($ millions)
Figure 54. Americas Acilizumab Sales Market Share by Country in 2025
Figure 55. Americas Acilizumab Revenue Market Share by Country (2021-2026)
Figure 56. Americas Acilizumab Sales Market Share by Type (2021-2026)
Figure 57. Americas Acilizumab Sales Market Share by Application (2021-2026)
Figure 58. United States Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Acilizumab Sales Market Share by Region in 2025
Figure 63. APAC Acilizumab Revenue Market Share by Region (2021-2026)
Figure 64. APAC Acilizumab Sales Market Share by Type (2021-2026)
Figure 65. APAC Acilizumab Sales Market Share by Application (2021-2026)
Figure 66. China Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. India Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Acilizumab Sales Market Share by Country in 2025
Figure 74. Europe Acilizumab Revenue Market Share by Country (2021-2026)
Figure 75. Europe Acilizumab Sales Market Share by Type (2021-2026)
Figure 76. Europe Acilizumab Sales Market Share by Application (2021-2026)
Figure 77. Germany Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. France Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Acilizumab Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Acilizumab Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Acilizumab Sales Market Share by Application (2021-2026)
Figure 85. Egypt Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Acilizumab Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Acilizumab in 2026
Figure 91. Manufacturing Process Analysis of Acilizumab
Figure 92. Industry Chain Structure of Acilizumab
Figure 93. Channels of Distribution
Figure 94. Global Acilizumab Sales Market Forecast by Region (2027-2032)
Figure 95. Global Acilizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Acilizumab Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Acilizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Acilizumab Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Acilizumab Revenue Market Share Forecast by Application (2027-2032)
